Lobbying client
SUMMIT THERAPEUTICS PLC
Biopharmaceutical company; develops medicines to treat infectious diseases
Filings
7
Filed by
1
Reported in-house
—
Reported by firms
$30,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2020 to 2021
Filings
7 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination (No Activity) 2nd Quarter 2021
|
THE KPM GROUP DC LLC | — reported |
|
2nd Quarter - Report (No Activity)replaced 2nd Quarter 2021
|
THE KPM GROUP DC LLC | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2021
|
THE KPM GROUP DC LLC | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2020
|
THE KPM GROUP DC LLC | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2020
|
THE KPM GROUP DC LLC | — reported |
|
2nd Quarter - Report 2nd Quarter 2020
|
THE KPM GROUP DC LLC | $30,000 reported |
|
Registration 2nd Quarter 2020
|
THE KPM GROUP DC LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| THE KPM GROUP DC LLC | 5 | $30,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Pharmacy | PHA | 2 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.